Vifor Pharma AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vifor Pharma AG generated cash of $527,400,000, which is more than the previous year. Cash used in financing activities reached the amount of -$210,900,000 last year. Net change in cash is therefore $263,600,000.
Cash Flow
| 2012 | 291.69M | -45.63M | -236.85M |
|---|---|---|---|
| 2013 | 329.04M | -108.31M | -353.14M |
| 2014 | 355.84M | -157.59M | -175.31M |
| 2015 | 522.20M | -162.13M | -175.95M |
| 2016 | 257.89M | -1.54B | 1.04B |
| 2017 | 60.3M | 2.06B | -1.88B |
| 2018 | 193.8M | -376.1M | 158.6M |
| 2019 | 524.8M | -132.5M | -238.5M |
| 2020 | 423.8M | 52.4M | -268.4M |
| 2021 | 527.4M | -48.8M | -210.9M |
GNHAY Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 730M | 544.9M | 400.3M | 425.1M | 180.9M | 422.19M | 238.52M | 215.58M | 347.91M | 338.68M |
Operating activities | ||||||||||
Net income | 144.4M | 359.6M | 159.1M | 152.4M | 1.14B | 243.62M | 301.06M | 284.45M | 296.16M | 253.46M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 319.9M | 284.4M | 215M | 164.1M | 146M | 127.57M | 86.59M | 76.62M | 75.67M | 76.05M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -24.4M | -20.9M | -68M | -50.4M | -63.9M | 1.90M | -10.56M | -21.96M | -7.82M | -4.80M |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 527.4M | 423.8M | 524.8M | 193.8M | 60.3M | 257.89M | 522.20M | 355.84M | 329.04M | 291.69M |
Investing activities | ||||||||||
Purchases Of Investments | -60.8M | -43.4M | -3.7M | -106.2M | -50.7M | -10.87M | -4.79M | -87.62M | -1.90M | -715K |
Investments In Property Plant And Equipment | -218.7M | -384.6M | -136.2M | -276M | -88.4M | -283.16M | -164.87M | -69.89M | -71.59M | -45.49M |
Acquisitions Net | -30.6M | 368M | 88.2M | 213.3M | 1.79B | -1.25B | -36.40M | -12.95M | -47.50M | -19.2M |
Cash generated by investing activities | -48.8M | 52.4M | -132.5M | -376.1M | 2.06B | -1.54B | -162.13M | -157.59M | -108.31M | -45.63M |
Financing activities | ||||||||||
Common Stock Issued | 3.2M | 4M | 2.5M | 3.5M | 5.4M | 9.78M | 10.08M | 7.98M | 7.76M | 3.49M |
Payments for dividends | -189.8M | -219.6M | -174.7M | -174.6M | -129.9M | -116.55M | -102.42M | -129.45M | -92.58M | -92.56M |
Repurchases of common stock | -5.8M | -28.9M | -11.7M | -19.5M | -1.5M | -18.11M | -20.26M | -13.90M | -21.65M | -11.46M |
Repayments of term debt | 0 | -900K | 0 | -118.4M | 0 | -323.29M | 0 | -73.25M | -281.32M | -165.97M |
Cash used in financing activities | -210.9M | -268.4M | -238.5M | 158.6M | -1.88B | 1.04B | -175.95M | -175.31M | -353.14M | -236.85M |
Net Change In Cash | 263.6M | 185.1M | 144.6M | -24.8M | 244.2M | -241.28M | 183.67M | 22.94M | -132.33M | 9.22M |
Cash at end of period | 993.6M | 730M | 544.9M | 400.3M | 425.1M | 180.91M | 422.19M | 238.52M | 215.58M | 347.91M |